Catherine Bollard, MD, associate center director for translational research and innovation at GW Cancer Center, was quoted by Interesting Engineering in an article about her recent study looking at the safety of a cell therapy involving expanding T-cells against HIV.
Interesting Engineering - First Ever HIV Immunotherapy Drug Proven Safe For Use in Humans
Latest News
The George Washington University (GW) Summer Program Advancing Research on Cancer (GW-SPARC) concluded its annual summer research experience on July 30 with a poster session where students presented their summer research.
Incoming first-year George Washington University medical students spend three days getting to know their classmates, exploring campus, and preparing for the years to come.
Sen. Tim Kaine (D–VA) and Rep. James Walkinshaw (D–VA-11) joined others for a day-long summit, “A Call to Conscience: Advancing Inclusion for Adults with Disabilities who have Significant Support Needs,” at the George Washington University, brought together people with disabilities, family members…
